Back to search
Spinocerebellar Ataxia (SCA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Spinocerebellar Ataxia (SCA) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Spinocerebellar Ataxia (SCA) trials you may qualify forThe purpose of this study is to leverage two sources of real-world data (RWD) to assess the effectiveness of troriluzole after three years of treatment in patie…
The purpose of this expanded access protocol is to provide access to the investigational drug troriluzole in patients with spinocerebellar ataxia (SCA).
This is a single-center, open-label study designed to evaluate the feasibility, safety, and preliminary efficacy of cerebellar adaptive deep brain stimulation (…